Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack
Closed for comments This consultation ended on at Request commenting lead permission
6 Review
NICE will regularly monitor its published technology guidance to check for any new evidence or information that could affect the recommendations. Guidance will not have a fixed review date.
Brian Shine
Chair, diagnostics advisory committee
May 2023
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions